title: How big a problem is heart failure with a normal ejection fraction?
authors.affiliation: Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands f.h.rutten@umcutrecht.nl.
authors.forename: Frans H
authors.initials: FH
authors.lastname: Rutten
authors.affiliation: Department of Cardiology, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, UK.
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Clark
authors.affiliation: Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
authors.forename: Arno W
authors.initials: AW
authors.lastname: Hoes
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D003951:Diagnostic Errors; D004232:Diuretics / Q000627:therapeutic use; D004417:Dyspnea / Q000209:etiology; D004452:Echocardiography; D004487:Edema / Q000209:etiology; D005081:Exercise Therapy; D006333:Heart Failure / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D011379:Prognosis; D011788:Quality of Life; D012720:Severity of Illness Index; D013318:Stroke Volume; D035501:Uncertainty
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain